The Drug Regulatory Authority of Pakistan (DRAP) has declared several batches of auto-disable syringes manufactured by six companies as substandard and issued a medical product alert.
In a statement, the DRAP has said 3ml and 5ml auto-disable syringes failed to meet required quality standards.
The decision was based on testing carried out by the Central Drugs Laboratory in Karachi, which found that three sampled batches of three syringes manufactured by three international companies did not comply with auto-disable functionality requirements.
According to the DRAP, the substandard batches include products from manufacturers based in China, Egypt, Punjab, and Khyber Pakhtunkhwa.
